https://www.selleckchem.com/products/mycmi-6.html
We evaluated 113 pediatric patients with chronic hepatitis C from 2009 to 2019 at a Brazilian tertiary center. Seventy patients received pegylated-interferon treatment. The sustained virologic response was 61.4%, and 92.8% reported side effects. Currently, we are following 39 patients with chronic hepatitis C, 24 of whom are eligible for treatment with direct-acting antivirals according to Brazilian recommendations.Background Abdominal tuberculosis (T in children is poorly described and often poses a diagnostic challenge. We evaluated
Like
Comment
Share
